Last updated: July 29, 2024
Sponsor: Mayo Clinic
Overall Status: Terminated
Phase
N/A
Condition
Sarcoma
Infantile Fibrosarcoma
Lung Cancer
Treatment
N/AClinical Study ID
NCT02613312
15-007645
NCI-2024-02057
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subject provides informed consent
Subject is >18 years of age
Subject is deemed competent for making medical decisions
Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT
Subject is a surgical candidate
A negative pregnancy test is required in women of child-bearing potential, asstandard of care.
Exclusion
Exclusion Criteria:
•Subject is <18 years old.
Study Design
Total Participants: 8
Study Start date:
March 18, 2016
Estimated Completion Date:
October 05, 2020
Study Description
Connect with a study center
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.